$OACC

Oaktree Acquisition Corp. III Life Sciences

0
1
1

No SEC Form 4 filings for $OACC in the last 30 days.

See all $OACC insider activity →
Low

Oaktree Acquisition Corp. III Life Sciences posts preliminary redemption and sponsor conversion results

Oaktree Acquisition Corp. III Life Sciences reported 13.3 million Class A shares tendered for redemption and a sponsor conversion of 4.8 million Class B shares to Class A. Post-redemption and conversion, 11.3 million Class A and 1,000 Class B shares will remain. The sponsor will hold 5.4 million Class A and 1,000 Class B shares, with converted shares retaining certain restrictions.

Oaktree Acquisition Corp. III Life Sciences filed a definitive proxy statement for an extraordinary general meeting in lieu of annual meeting of its…

Oaktree Acquisition Corp. III Life Sciences (OACC) filed an SEC Form 8-K — Regulation FD Disclosure. Item 7.01. Regulation FD Disclosure. Preliminary Redemption Results On October 2, 2026, Oaktree Acquisition Corp. III Life Sciences (“ OAC ”) filed a definitive proxy statement (the “ Extension Proxy Statement ”) for an extraordinary general meeting in lieu of annual meeting of i

OACC sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning OACC (Oaktree Acquisition Corp. III Life Sciences). Coverage has skewed bearish: 0 bullish, 1 neutral, and 1 bearish.

What's driving OACC

  • Redemption reduces public float while sponsor conversion increases insider ownership, likely pressuring the share price modestly.

    tradingview.com · Oct 15, 2026

  • Redemption reduces public float while sponsor conversion creates non‑redeemable founder shares, likely diluting existing shareholders.

    SEC EDGAR 8-K · Oct 15, 2026

AlphAI scores every news story that mentions OACC with an AI model for sentiment and relevance, and aggregates insider trades from Oaktree Acquisition Corp. III Life Sciences's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $OACC

Score

Oaktree Acquisition Corp. III Life Sciences posts preliminary redemption and sponsor conversion results

Oaktree Acquisition Corp. III Life Sciences reported 13.3 million Class A shares tendered for redemption and a sponsor conversion of 4.8 million Class B shares to Class A. Post-redemption and conversion, 11.3 million Class A and 1,000 Class B shares will remain. The sponsor will hold 5.4 million Class A and 1,000 Class B shares, with converted shares retaining certain restrictions.

$OACCLow

Oaktree Acquisition Corp. III Life Sciences filed a definitive proxy statement for an extraordinary general meeting in lieu of annual meeting of its…

Oaktree Acquisition Corp. III Life Sciences (OACC) filed an SEC Form 8-K — Regulation FD Disclosure. Item 7.01. Regulation FD Disclosure. Preliminary Redemption Results On October 2, 2026, Oaktree Acquisition Corp. III Life Sciences (“ OAC ”) filed a definitive proxy statement (the “ Extension Proxy Statement ”) for an extraordinary general meeting in lieu of annual meeting of i

Related tickers